Abzena, an integrated CDMO + CRO for complex biologics and bioconjugates, has named Taylor Boyd Chief Business Officer. In ...
Tjoapack, a provider of packaging services for the pharmaceutical industry, has successfully produced its first Pre-Filled ...
Signs a strategic collaboration and license agreement to advance novel therapies targeting corticotropin-releasing hormone ...
ImmunoPrecise Antibodies Ltd., an AI-powered antibody company, has partnered with RIBOPRO, a technology provider specializing ...
Ignota Labs, an AI-driven drug turnaround company, has closed a $6.9 million seed funding round, co-led by Montage Ventures ...
Nimbus Therapeutics, LLC, a biotechnology company that designs and develops medicines leveraging its computational drug discovery engine, has achieved a significant preclinical milestone under its ...
IsomAb Ltd, a UK-based biotechnology company developing novel isoform-specific disease modifying antibody treatments, for peripheral arterial disease and other ischaemic conditions, has appointed Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback